Cagrilintide + Semaglutide

What is it?

Cagrilintide + Semaglutide is a dual-peptide blend studied in laboratory settings for its combined activity on amylin and GLP-1 receptor pathways. Cagrilintide is an amylin receptor agonist, while Semaglutide is a GLP-1 receptor agonist; together, they are used in controlled experimental models to investigate appetite regulation, glucose metabolism, gastric emptying, and energy balance mechanisms. This combination is of interest in research exploring synergistic receptor interactions and integrated metabolic signaling pathways. Supplied as a lyophilized powder, this blend is suitable for studies focused on peptide pharmacology and multi-pathway metabolic modulation. Supplied as: Lyophilized powder Purity: 98–99%+ (HPLC verified) Storage: Store desiccated at -20°C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.